Early Progressive Renal Decline Precedes the Onset of Microalbuminuria and Its Progression to Macroalbuminuria

OBJECTIVE Progressive decrease in the glomerular filtration rate (GFR), or renal decline, in type 1 diabetes (T1D) is observed in patients with macroalbuminuria. However, it is unknown whether this decline begins during microalbuminuria (MA) or normoalbuminuria (NA). RESEARCH DESIGN AND METHODS The study group (second Joslin Kidney Study) comprises patients with T1D and NA (n = 286) or MA (n = 248) who were followed for 4–10 years (median 8 years). Serial measurements (median 6, range 3–16) of serum creatinine and cystatin C were used jointly to estimate GFR (eGFRcr-cys) and assess its trajectories during follow-up. RESULTS Renal decline (progressive eGFRcr-cys loss of at least 3.3% per year) occurred in 10% of the NA and 35% of the MA (P < 0.001). In both groups, the strongest determinants of renal decline were baseline serum concentrations of uric acid (P < 0.001) and tumor necrosis factor receptor 1 or 2 (TNFR-1 or -2, P < 0.001). Other significant risk factors included baseline HbA1c, age/diabetes duration, and systolic blood pressure. Relative impacts of these determinants were similar in NA and MA. Renal decline was not associated with sex or baseline serum concentration of TNF-α, IL-6, IL-8, IP-10, MCP-1, VCAM, ICAM, Fas, or FasL. CONCLUSIONS Renal decline in T1D begins during NA and it is determined by multiple factors, similar to MA. Thus, this early decline is the primary disease process leading to impaired renal function in T1D. Changes in albumin excretion rate, such as the onset of MA or its progression to macroalbuminuria, are either caused by or develop in parallel to the early renal decline.

[1]  T. Nakagawa,et al.  Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. , 2002, American journal of physiology. Renal physiology.

[2]  R. Holman,et al.  Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR; for the UKPDS Study Group. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes 2006;55:1832―1839 , 2011 .

[3]  J. H. Acosta,et al.  Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link? , 2005, Journal of the American Society of Nephrology : JASN.

[4]  P. Fiorina,et al.  Can existing drugs approved for other indications retard renal function decline in patients with type 1 diabetes and nephropathy? , 2012, Seminars in nephrology.

[5]  E. Block,et al.  Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells. , 2008, American journal of physiology. Cell physiology.

[6]  L. Truong,et al.  A role for uric acid in the progression of renal disease. , 2002, Journal of the American Society of Nephrology : JASN.

[7]  K. Leung,et al.  Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  Samy Suissa,et al.  Renal and retinal effects of enalapril and losartan in type 1 diabetes. , 2009, The New England journal of medicine.

[9]  B. Zinman,et al.  Development and Progression of Renal Insufficiency With and Without Albuminuria in Adults With Type 1 Diabetes in the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications Study , 2010, Diabetes Care.

[10]  A. Krolewski,et al.  Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes. , 2009, American Society of Nephrology. Clinical Journal.

[11]  T. Mayadas,et al.  Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. , 2012, Journal of the American Society of Nephrology : JASN.

[12]  B. Trump,et al.  2 The Kidney , 1969 .

[13]  R. Garrick Intensive Diabetes Therapy and Glomerular Filtration Rate in Type 1 Diabetes , 2012 .

[14]  S. Satchell,et al.  Diabetic nephropathy. , 2012, Clinical medicine.

[15]  J. Skupień,et al.  The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end stage renal disease , 2012, Kidney international.

[16]  Harold I Feldman,et al.  Estimating glomerular filtration rate from serum creatinine and cystatin C. , 2012, The New England journal of medicine.

[17]  A. Krolewski,et al.  In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria. , 2010, Kidney international.

[18]  C. Mogensen,et al.  Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas , 1999, Diabetologia.

[19]  N W Shock,et al.  Longitudinal Studies on the Rate of Decline in Renal Function with Age , 1985, Journal of the American Geriatrics Society.

[20]  Duk-Hee Kang,et al.  Oxidative stress with an activation of the renin–angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction , 2010, Journal of hypertension.

[21]  A. Galecki,et al.  High-Normal Serum Uric Acid Increases Risk of Early Progressive Renal Function Loss in Type 1 Diabetes , 2010, Diabetes Care.

[22]  K. Terplán,et al.  The Kidney in Gout , 1960, Medicine.

[23]  J. Dubernard,et al.  [The kidney]. , 2011, Bulletin de l'Academie nationale de medecine.

[24]  C. Tsalamandris,et al.  Progressive Decline in Renal Function in Diabetic Patients With and Without Albuminuria , 1994, Diabetes.

[25]  G. Gearin,et al.  Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. , 1996, Journal of the American Society of Nephrology : JASN.

[26]  J. Weinberg,et al.  Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. , 2007, Journal of the American Society of Nephrology : JASN.

[27]  Richard Barnett Diabetes , 1904, The Lancet.

[28]  R. Nelson,et al.  Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. , 2005, Journal of the American Society of Nephrology : JASN.

[29]  C. Forsblom,et al.  Serum Concentration of Cystatin C and Risk of End-Stage Renal Disease in Diabetes , 2012, Diabetes Care.

[30]  T. Mayadas,et al.  Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. , 2012, Journal of the American Society of Nephrology : JASN.